How Are Nektar Therapeutics(NADSAQ:NKTR) and ImmunoGen, Inc.(NASDAQ:IMGN) Aiming For Success In The Biotechnology Industry?

Posted by Saimoon October 9, 2014 0 Comment 1043 views


New York, NY – GDP INSIDER  –  10/09/2014.

This article discusses the recent news surrounding two biotechnology companies: Nektar Therapeutics(NADSAQ:NKTR) and ImmunoGen, Inc.(NASDAQ:IMGN)

As of Oct. 8th, Nektar Therapeutics(NASDAQ:NKTR) had a bid price of $12.15 x 100 and an offer price of $13.89 x 100, figures that indicate the stock might be a tad bit too liquid for investors. The California-based clinical stage biopharmaceutical company announced Sept. 26th that its MOVENTIG product had receive a positive CHMP opinion in the European Union for the treatment of adults with opioid-induced constipation.

The product is specifically designed to help patients who are not receiving a positive result to traditional laxatives and use opioid pain medicines. As the description of the drug implies, MOVENTIG would potentially be used for a very specific niche. However, patients who may have turned away from opioid medications due to constipation symptoms may be persuaded to use them again due to the effectiveness ofMOVENTIG, which might increase the usage of the Nektar drug in Europe.

Will MOVENTIG Become A Hit In Europe? View Our Free NKTR Analysis.

ImmunoGen, Inc.(NASDAQ:IMGN), like Nektar Therapeutics, is also a highly-liquid stock with a bid price of $8.99 x 2,700 and an offer price of $11.17 x 2,000. The California-based biotechnology company develops targeted anticancer therapeutics.

On Sept. 15th, the company announced that it had appointed Sandra E. Poole to the position of Senior Vice President of Technical Operations. In that role, Poole will be tasked with using her twenty-five years of related experience to the company’s preparations for later-stage trials.

Given the fact that the company traded for as little as $8.99 during yesterday’s trading, a new 52 week low for the company, ImmunoGen clearly needs for its later-stage trials to be successful.

Where Will ImmunoGen’s Trading Price Sit In Six Months? Take A Look At Our Free IMGN Analysis.

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment